Advancing Targeted AMR Research
PALDARA’s research program is focused on bacteriophage therapeutics and biomaterial-enabled delivery systems designed to address multidrug-resistant infections with precision, adaptability, and translational potential.
Research Focus
Core scientific priorities
Our platform research integrates phage biology, biomaterials engineering, and infection-focused translational development to create targeted therapeutic solutions for urgent clinical needs.
Phage Discovery
Identification and characterization of bacteriophages with activity against clinically significant multidrug-resistant pathogens.
Delivery Platforms
Development of hydrogel and biomaterial systems that improve localized delivery, stability, and therapeutic performance.
Preclinical Evaluation
Assessment of antibacterial efficacy, formulation behavior, and safety across relevant laboratory and translational models.
Resistance Strategy
Research programs designed to reduce dependence on conventional antibiotics and support more precise antimicrobial interventions.
Platform Approach
Designed for precision and translation
PALDARA is building a research framework that pairs the specificity of bacteriophages with advanced biomaterial delivery to support targeted intervention at the site of infection.
Targeted Action
Phage-based approaches are selected for pathogen specificity, supporting focused antibacterial activity.
Localized Delivery
Hydrogel-enabled formulations are being developed to improve retention, control release, and enhance therapeutic utility.
Research Areas
Programs in development
Our research activities span discovery, formulation, and translational investigation to support next-generation antibacterial therapeutics.
